Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects

被引:9
作者
van Esdonk, Michiel J. [1 ,2 ]
Lindeman, Ian [1 ]
Okkerse, Pieter [1 ]
de Kam, Marieke L. [1 ]
Groeneveld, Geert J. [1 ]
Stevens, Jasper [3 ]
机构
[1] Ctr Human Drug Res, Leiden, Netherlands
[2] Leiden Univ, Div Syst Biomed & Pharmacol, Leiden Acad Ctr Drug Res, Leiden, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
来源
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY | 2018年 / 7卷 / 09期
关键词
CLINICAL PHARMACOKINETICS;
D O I
10.1002/psp4.12318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A battery of pain models can be used in clinical trials to investigate the efficacy and to establish the concentration-effect relationship of novel analgesics. This study quantified the pharmacokinetics (PK) of pregabalin after a single oral dose of 300mg and the pharmacodynamics (PD) on the pain tolerance threshold (PTT) of the cold pressor, electrical stimulation, the pressure pain model, and on the pain detection threshold of a contact heat pain model. The PK were best described using a one-compartment model with lag time, linear absorption, and linear elimination. The PTT of the cold pressor showed a negative linear decrease over time without pregabalin. A linear drug effect was identified on the PTT of the cold pressor test and an on/off effect for the electrical stimulation PTT. No PK/PD relationship could be identified on the pressure pain and heat pain test. Citation:
引用
收藏
页码:573 / 580
页数:8
相关论文
共 28 条
  • [1] Beal SL., 2013, NONMEM 7 3 0 USERS G
  • [2] Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers
    Bockbrader, Howard N.
    Radulovic, Louis L.
    Posvar, Edward L.
    Strand, James C.
    Alvey, Christine W.
    Busch, Janice A.
    Randinitis, Edward J.
    Corrigan, Brian W.
    Haig, George M.
    Boyd, Rebecca A.
    Wesche, David L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08) : 941 - 950
  • [3] Exposure-Response Analyses of the Effects of Pregabalin in Patients With Fibromyalgia Using Daily Pain Scores and Patient Global Impression of Change
    Byon, Wonkyung
    Ouellet, Daniele
    Chew, Marci
    Ito, Kaori
    Burger, Paula
    Pauer, Lynne
    Zeiher, Bernhardt
    Corrigan, Brian
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (07) : 803 - 815
  • [4] CLINICAL PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN ALCOHOLICS AND NORMAL VOLUNTEERS
    CIRAULO, DA
    BARNHILL, JG
    JAFFE, JH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 509 - 518
  • [5] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [6] The α2δ subunits of voltage-gated calcium channels
    Dolphin, Annette C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2013, 1828 (07): : 1541 - 1549
  • [7] Grimmer-Somers Karen, 2009, J Pain Res, V2, P21
  • [8] Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
    Hay, Justin L.
    Okkerse, Pieter
    van Amerongen, Guido
    Groeneveld, Geert Jan
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (110):
  • [9] Comparison of oral absorption models for pregabalin: usefulness of transit compartment model
    Hong, Taegon
    Han, Seunghoon
    Lee, Jongtae
    Jeon, Sangil
    Yim, Dong-Seok
    [J]. Drug Design Development and Therapy, 2016, 10 : 3995 - 4003
  • [10] Quantification of lean bodyweight
    Janmahasatian, S
    Duffull, SB
    Ash, S
    Ward, LC
    Byrne, NM
    Green, B
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (10) : 1051 - 1065